Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 A case of new-onset antibody-positive myasthenia gravis in a patient treated with pembrolizumab for melanoma.

× No keyword cloud information.

9 in total

1. Cascade of immunologic adverse events related to pembrolizumab treatment.

Authors: Arnaud Dhenin; Vassiliki Samartzi; Sarah Lejeune; Emmanuel Seront
Journal: BMJ Case Rep Date: 2019-06-04

Review 2. Neurological Complications of Therapeutic Monoclonal Antibodies: Trends from Oncology to Rheumatology.

Authors: Chandler Gill; Stasia Rouse; Ryan D Jacobson
Journal: Curr Neurol Neurosci Rep Date: 2017-08-17 Impact factor: 5.081

3. Myasthenia gravis with myositis induced by pembrolizumab therapy in a patient with metastatic urothelial carcinoma.

Authors: Nozomi Hayakawa; Eiji Kikuchi; Shigeaki Suzuki; Mototsugu Oya
Journal: Int Cancer Conf J Date: 2020-03-21

Review 4. Neuromuscular Complications of Programmed Cell Death-1 (PD-1) Inhibitors.

Authors: Justin C Kao; Adipong Brickshawana; Teerin Liewluck
Journal: Curr Neurol Neurosci Rep Date: 2018-08-04 Impact factor: 5.081

5. Pembrolizumab-induced myasthenia gravis with myositis in a patient with lung cancer.

Authors: Makoto Hibino; Kazunari Maeda; Shigeto Horiuchi; Minoru Fukuda; Tetsuri Kondo
Journal: Respirol Case Rep Date: 2018-08-07

Review 6. Neuro-ophthalmic Complications of Immune Checkpoint Inhibitors: A Systematic Review.

Authors: Caberry W Yu; Matthew Yau; Natalie Mezey; Ishraq Joarder; Jonathan A Micieli
Journal: Eye Brain Date: 2020-11-03

7. Association Between Clinical Factors and Result of Immune Checkpoint Inhibitor Related Myasthenia Gravis: A Single Center Experience and Systematic Review.

Authors: Jiayu Shi; Ying Tan; Yangyu Huang; Ke Li; Jingwen Yan; Yuzhou Guan; Li Zhang
Journal: Front Neurol Date: 2022-04-07 Impact factor: 4.003

8. Immune checkpoint inhibitors in the onset of myasthenia gravis with hyperCKemia.

Authors: Koutaro Takamatsu; Shunya Nakane; Shigeaki Suzuki; Takayuki Kosaka; Satoshi Fukushima; Toshihiro Kimura; Azusa Miyashita; Akihiro Mukaino; Shiori Yamakawa; Keisuke Watanabe; Masatoshi Jinnin; Yoshihiro Komohara; Hironobu Ihn; Yukio Ando
Journal: Ann Clin Transl Neurol Date: 2018-09-23 Impact factor: 4.511

Review 9. Immune Checkpoint Inhibitors and Neurotoxicity.

Authors: Zhiyi Zhao; Chunlin Zhang; Lian Zhou; Pan Dong; Lei Shi
Journal: Curr Neuropharmacol Date: 2021 Impact factor: 7.363

9 in total